Physician profile
Megan E Moore
NPI 1457647893
$803.52
in general payments reported to CMS, 2019-2025
8 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $142 · 2022: $13.63 · 2023: $456 · 2024: $23.05 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $647.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $321.33 | 2021-2023 | Tezspire |
| Csl Behring | $157.49 | 2023-2025 | Hizentra, Haegarda |
| Pfizer INC. | $123.23 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $63.88 | 2021-2025 | Dupixent |
| Ars Pharmaceuticals Operations, INC. | $57.29 | 2025 | Neffy |
| Genzyme Corporation | $29.44 | 2025 | |
| Glaxosmithkline, LLC. | $27.81 | 2021-2025 | Trelegy Ellipta |
| Octapharma USA, INC. | $23.05 | 2024 | Cutaquig |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.